This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Akouos Future Growth
Future criteria checks 0/6
Key information
32.1%
Earnings growth rate
34.9%
EPS growth rate
| Biotechs earnings growth | 23.2% |
| Revenue growth rate | 93.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
Recent updates
Is Akouos (NASDAQ:AKUS) In A Good Position To Deliver On Growth Plans?
Sep 19
Akouos stock rises 11% on FDA nod to start gene therapy trial for hearing loss
Sep 13We Think Akouos (NASDAQ:AKUS) Needs To Drive Business Growth Carefully
Jun 04We Think Akouos (NASDAQ:AKUS) Can Afford To Drive Business Growth
Feb 19Companies Like Akouos (NASDAQ:AKUS) Are In A Position To Invest In Growth
Oct 28Here's Why We're Not Too Worried About Akouos' (NASDAQ:AKUS) Cash Burn Situation
Jun 26Akouos names Kathy Reape as chief development officer
May 07We Think Akouos (NASDAQ:AKUS) Can Afford To Drive Business Growth
Mar 04Did Akouos, Inc. (NASDAQ:AKUS) Insiders Buy Up More Shares?
Jan 10Akouos (NASDAQ:AKUS) Is In A Good Position To Deliver On Growth Plans
Nov 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 10 | -137 | N/A | -87 | 3 |
| 12/31/2023 | N/A | -117 | N/A | -73 | 4 |
| 12/31/2022 | N/A | -98 | N/A | -77 | 4 |
| 9/30/2022 | N/A | -93 | -87 | -74 | N/A |
| 6/30/2022 | N/A | -96 | -85 | -73 | N/A |
| 3/31/2022 | N/A | -98 | -76 | -68 | N/A |
| 12/31/2021 | N/A | -87 | -73 | -64 | N/A |
| 9/30/2021 | N/A | -74 | -68 | -58 | N/A |
| 6/30/2021 | N/A | -64 | -58 | -49 | N/A |
| 3/31/2021 | N/A | -54 | -56 | -48 | N/A |
| 12/31/2020 | N/A | -49 | -45 | -41 | N/A |
| 9/30/2020 | N/A | -46 | -44 | -38 | N/A |
| 6/30/2020 | N/A | -41 | -37 | -33 | N/A |
| 3/31/2020 | N/A | -30 | -29 | -25 | N/A |
| 12/31/2019 | N/A | -26 | -23 | -20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AKUS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AKUS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AKUS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AKUS is forecast to have no revenue next year.
High Growth Revenue: AKUS is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AKUS's Return on Equity is forecast to be high in 3 years time